Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George W. Holland

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Combinatorial Chemistry|July 9, 2002
Solution-phase parallel synthesis of substituted benzimidazolesB Raju, Noel Nguyen, George W Holland
Idrugs : the Investigational Drugs Journal|June 6, 2003
Recently discovered sulfonamide-, acyl sulfonamide- and carboxylic acid-based endothelin antagonistsChengde Wu, George W Holland, Tommy A Brock, et al.
Pulmonary Pharmacology & Therapeutics|December 4, 2003
Development of cell adhesion molecule antagonists as therapeutics for asthma and COPDPeter Vanderslice, Ronald J Biediger, Darren G Woodside, et al.
Drugs of Today (Barcelona, Spain : 1998)|May 17, 2003
Nonpeptide endothelin antagonists in clinical developmentChengde Wu, E. Radford Decker, George W. Holland, et al.
Biophysical Journal|December 26, 2001
A 3D structure model of integrin alpha 4 beta 1 complex: I. Construction of a homology model of beta 1 and ligand binding analysisTony J You, David S Maxwell, Timothy P Kogan, et al.
Journal of Medicinal Chemistry|April 2, 2004
Discovery, modeling, and human pharmacokinetics of N-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide (TBC3711), a second generation, ETA selective, and orally bioavailable endothelin antagonistChengde Wu, E Radford Decker, Natalie Blok, et al.
Journal of Medicinal Chemistry|April 22, 2010
Discovery, structure-activity relationships, pharmacokinetics, and efficacy of glucokinase activator (2R)-3-cyclopentyl-2-(4-methanesulfonylphenyl)-N-thiazol-2-yl-propionamide (RO0281675)Nancy-Ellen Haynes, Wendy L Corbett, Fred T Bizzarro, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Combinatorial Chemistry|July 9, 2002
Solution-phase parallel synthesis of substituted benzimidazolesB Raju, Noel Nguyen, George W Holland
Idrugs : the Investigational Drugs Journal|June 6, 2003
Recently discovered sulfonamide-, acyl sulfonamide- and carboxylic acid-based endothelin antagonistsChengde Wu, George W Holland, Tommy A Brock, et al.
Pulmonary Pharmacology & Therapeutics|December 4, 2003
Development of cell adhesion molecule antagonists as therapeutics for asthma and COPDPeter Vanderslice, Ronald J Biediger, Darren G Woodside, et al.
Drugs of Today (Barcelona, Spain : 1998)|May 17, 2003
Nonpeptide endothelin antagonists in clinical developmentChengde Wu, E. Radford Decker, George W. Holland, et al.
Biophysical Journal|December 26, 2001
A 3D structure model of integrin alpha 4 beta 1 complex: I. Construction of a homology model of beta 1 and ligand binding analysisTony J You, David S Maxwell, Timothy P Kogan, et al.
Journal of Medicinal Chemistry|April 2, 2004
Discovery, modeling, and human pharmacokinetics of N-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide (TBC3711), a second generation, ETA selective, and orally bioavailable endothelin antagonistChengde Wu, E Radford Decker, Natalie Blok, et al.
Journal of Medicinal Chemistry|April 22, 2010
Discovery, structure-activity relationships, pharmacokinetics, and efficacy of glucokinase activator (2R)-3-cyclopentyl-2-(4-methanesulfonylphenyl)-N-thiazol-2-yl-propionamide (RO0281675)Nancy-Ellen Haynes, Wendy L Corbett, Fred T Bizzarro, et al.
Pageof 1